Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
58 hedge funds and large institutions have $34.6M invested in Vaxart in 2014 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 12 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 16
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
2% less funds holding
Funds holding: 59 → 58 (-1)
55% less capital invested
Capital invested by funds: $77.3M → $34.6M (-$42.7M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $516K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$1.84M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.29M |
| 3 |
Goldman Sachs
New York
|
+$453K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$441K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$387K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$7.03M |
| 2 |
6CM
683 Capital Management
New York
|
-$1.05M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$646K |
| 4 |
PA
Perceptive Advisors
New York
|
-$614K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$515K |
VXRT Hedge Fund Activity: Q2 2014 in Review
58 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2014, worth a combined $34.6M — down 55% from $77.3M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of VXRT and 11 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 18 added.
The largest buyer was Broadfin Capital, adding an estimated $1.84M. The largest seller was HealthCor Management, exiting entirely with an estimated $7.03M sold.
- 58 institutional investors held Vaxart (VXRT) as of Q2 2014, down from 59 in Q1 2014.
- Funds reported $34.6M of Vaxart stock for Q2 2014, down 55% quarter-over-quarter.
- 11 funds opened new Vaxart positions in Q2 2014 and 12 closed out, a net change of -1 holder.
- The largest Vaxart buyer in Q2 2014 was Broadfin Capital, an estimated $1.84M added.
- The largest Vaxart seller in Q2 2014 was HealthCor Management, an estimated $7.03M sold.
Based on aggregated 13F filings for Q2 2014.